Immunohistochemistry analysis revealed that in ovarian cancer specimens with high SORBS2 expression, expression of WFDC1 and IL-17D was also reduced in both primary and metastatic foci of ovarian cancer (Fig. 5a and Additional file 2: Figure S12a). The gene discussed is SORBS2; the disease is ovarian carcinoma.